LEXARIA BIOSCIENCE CORP. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, other for the quarter ending 2022-05-31 was -$300.00K.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, other for the quarter ending 2022-02-28 was $1.20M.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, other for the quarter ending 2021-08-31 was $85.00K.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, other for the quarter ending 2021-05-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, other for fiscal 2021 was $85.00K, a 15.00% decline from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, other for fiscal 2020 was $100.00K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2022-05-31 | -$300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | |
| 2022-02-28 | $1.20M 10-Q · filed 2022-07-14 | |
| 2021-08-31 | $85.00K 10-Q · filed 2022-04-11 | $85.00K 10-K · filed 2021-11-29 |
| 2021-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | |
| 2020-08-31 | $100.00K 10-K · filed 2021-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |